GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT) » Definitions » Cyclically Adjusted Price-to-FCF

Sartorius AG (XTER:SRT) Cyclically Adjusted Price-to-FCF : 97.36 (As of May. 03, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG Cyclically Adjusted Price-to-FCF?

As of today (2024-05-03), Sartorius AG's current share price is €221.00. Sartorius AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €2.27. Sartorius AG's Cyclically Adjusted Price-to-FCF for today is 97.36.

The historical rank and industry rank for Sartorius AG's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

XTER:SRT' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 87.28   Med: 287.31   Max: 664.96
Current: 99.99

During the past years, Sartorius AG's highest Cyclically Adjusted Price-to-FCF was 664.96. The lowest was 87.28. And the median was 287.31.

XTER:SRT's Cyclically Adjusted Price-to-FCF is ranked worse than
81.7% of 235 companies
in the Medical Devices & Instruments industry
Industry Median: 41.21 vs XTER:SRT: 99.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sartorius AG's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €-1.197. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €2.27 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sartorius AG Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Sartorius AG's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Cyclically Adjusted Price-to-FCF Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 397.76 481.58 358.26 169.34 110.76

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 149.69 121.07 121.58 110.76 121.13

Competitive Comparison of Sartorius AG's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Sartorius AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Cyclically Adjusted Price-to-FCF falls into.



Sartorius AG Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Sartorius AG's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=221.00/2.27
=97.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sartorius AG's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.197/123.6675*123.6675
=-1.197

Current CPI (Mar. 2024) = 123.6675.

Sartorius AG Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.053 99.543 -0.066
201409 0.109 99.823 0.135
201412 0.568 99.543 0.706
201503 -0.111 99.717 -0.138
201506 0.342 100.417 0.421
201509 0.121 100.417 0.149
201512 -0.146 99.717 -0.181
201603 -0.154 100.017 -0.190
201606 -0.627 100.717 -0.770
201609 -1.358 101.017 -1.663
201612 2.094 101.217 2.558
201703 -0.209 101.417 -0.255
201706 -0.153 102.117 -0.185
201709 0.192 102.717 0.231
201712 0.326 102.617 0.393
201803 -0.023 102.917 -0.028
201806 -0.079 104.017 -0.094
201809 0.224 104.718 0.265
201812 0.045 104.217 0.053
201903 0.725 104.217 0.860
201906 0.009 105.718 0.011
201909 0.507 106.018 0.591
201912 0.979 105.818 1.144
202003 0.996 105.718 1.165
202006 0.850 106.618 0.986
202009 1.750 105.818 2.045
202012 0.382 105.518 0.448
202103 2.149 107.518 2.472
202106 2.120 108.486 2.417
202109 1.496 109.435 1.691
202112 1.020 110.384 1.143
202203 1.407 113.968 1.527
202206 -0.384 115.760 -0.410
202209 0.504 118.818 0.525
202212 1.563 119.345 1.620
202303 0.976 122.402 0.986
202306 -0.061 123.140 -0.061
202309 0.695 124.195 0.692
202312 2.708 123.668 2.708
202403 -1.197 123.668 -1.197

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sartorius AG  (XTER:SRT) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Sartorius AG Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (XTER:SRT) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.